An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice

Brain Research Bulletin

Volumn 39, Issue 3, 1996, Pages 185-188

  Kest, Benjamin ^a   Lee, Cynthia E ^a   McLemore, Gabrielle L ^a   Inturrisi, Charles E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Delta opioid receptor; Morphine analgesia; Physical dependence; Tolerance

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DELTA OPIATE RECEPTOR; MESSENGER RNA; MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG TOLERANCE; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL;

EID: 0030045115     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(95)02092-6     Document Type: Article

References (26)

1. Abdelhamid, E. E.; Sultana, M.; Portoghese, P. S.; Takemori, A. E. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258:299-303; 1991.
2. Abdelhamid, E. E.; Takemori, A. E. Characteristics of μ and δ opioid binding sites in striatal slices of morphine-tolerant and -dependent mice. Eur. J. Pharmacol. 198:157-163; 1991.
3. Cha, X. Y.; Xu, H.; Rice, K. C.; Porreca, F.; Lai, J.; Ananthan, S.; Rothman, R. B. Opioid peptide receptor studies. 1. Identification of a novel δ-opioid receptor binding site in rat brain membranes. Peptides 16:191-198; 1995.
4. Cotton, R.; Giles, M. G.; Miller, L.; Shaw, J. S.; Timms, D. ICI 174864: A highly selective antagonist for the opioid δ-receptor. Eur. J. Pharmacol. 97:331-332; 1984.
5. Haley, T. J.; McCormick, W. G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12:12-15; 1957.
6. 5-enkephalin binding sites in rat brain membranes. Life Sci. 31:2359-2362; 1982.
7. Jiang, Q.; Mosberg, H. I.; Porreca, F. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J. Pharmacol. Exp. Ther. 254:683-689; 1990.
8. 6]Enkephalin and naltrindole 5′-isothyocyanate: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257:1069-1075; 1991.
9. Kest, B.; Jenab, S.; Inturrisi, C. E. Levels of delta opioid receptor mRNA in morphine tolerant mice. Analgesia 1:195-200; 1995.
10. 2-agonist antinociception. Neuroreport 5:1049-1052; 1994.
11. Lee, C. E.; Kest, B.; Jenab, S.; Inturrisi, C. E. Effect of antisense oligodeoxynucleotide (ODN) on delta opioid receptor mRNA in CD-1 mice. Int. Narc. Res. Conf. Ab. 24; 1995.
12. 2]deltorphin II in mice: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258:583-587; 1991.
13. Miyamoto, Y.; Bowen, W. D.; Portoghese, P. S.; Takemori, A. E. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice. J. Pharmacol. Exp. Ther. 270:37-39; 1994.
14. Miyamoto, Y.; Portoghese, P. S.; Takemori, A. E. Involvement of delta; opioid receptors in the development of morphine dependence in mice. J. Pharmacol. Exp. Ther. 264:1141-1145; 1993.
15. Porreca, F.; Takemori, A. E.; Sultana, M.; Portoghese, P. S.; Bowen, W. D.; Mosberg, H. I. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J. Pharmacol. Exp. Ther. 263:147-152; 1992.
16. Portoghese, P. S.; Sultana, M.; Takemori, A. E. Naltrindole, a highly selective and potent nonpeptide 4 opioid receptor antagonist. Eur. J. Pharmacol. 146:185-186; 1988.
17. Portoghese, P. S.; Sultana, M.; Takemori, A. E. Naltrindole 5′-isothiocyanate: A nonequilibrium, highly selective δ opioid receptor antagonist. J. Med. Chem. 33:1547-1548; 1990.
18. Raynor, K.; Kong, H.; Chen, Y.; Yasuda, K.; Yu, L.; Bell, G. I.; Reisine, T. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:330-334; 1994.
19. Rothman, R. B.; Danks, J. A.; Jacobson, A. E.; Burke Jr., T. R.; Rice, K. C.; Tortella, F. C.; Holaday, J. W. Morphine tolerance increases μ-noncompetitive δ binding sites. Eur. J. Pharmacol. 124:113-119; 1986.
20. Sofuoglu, M.; Portoghese, P. S.; Takemori, A. E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257:676-680; 1991.
21. Standifer, K. M.; Chien, C.-C.; Wahlestedt, C.; Brown, G. P.; Pasternak, G. W. Selective loss of b opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron 12:805-810; 1994.
22. Standifer, K. M.; Jenab, S.; Su, W.; Chien, C.-C.; Pan, Y. X.; Inturrisi, C. E.; Pasternak, G. W. Antisense oligodeoxynucleotides to the cloned δ receptor, DOR-1: Uptake, stability, and regulation of gene expression. J. Neurochem. 65:1981-1987; 1995.
23. Takemori, A. E.; Portoghese, P. S. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in β-funaltrexamine-treated mice. J. Pharmacol. Exp. Ther. 243:91-94; 1987.
24. Traynor, J. R.; Elliott, J. δ-Opioid receptor subtypes and cross-talk with μ-receptors. Trends Pharmacol. Sci. 14:84-86; 1993.
25. Umans, J. G.; Inturrisi, C. E. Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine, and morphine in mice. J. Pharmacol. Exp. Ther. 218:409-415; 1981.
26. Vaught, J. L.; Takemori, A. E. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J. Pharmacol. Exp. Ther. 208:86-90; 1979.